Previous studies have shown that SERPINB9 directly inhibits granzyme B, a major effector of CD+ 8 T cell cytotoxicity, and leads to resistance to cytolytic T cell killing in cancer cells, making it a plausible candidate (32, 36). The gene discussed is GZMB; the disease is cancer.